Internship Host Institutions (IHI)
The SJSU SCILL consortium with the collaborative effort of Stanford University, UC Santa Cruz, The Parkinson's Institute, Biotime, and Stem Cell Theranostics, prepare and train graduate-level students in stem cell research.
The Host Institutions offer a diverse array of research interests in Regenerative Medicine with the state-of-the-art-technology. Each institution works closely with the interns to provide them with experience and laboratory skills that will allow them to take advantage of career opportunities in stem cell research.
Founded in 1988, The Parkinson's Institute and Clinical Center (PI) is America's only independent non-profit organization that provides basic and clinical research, clinical trials and a comprehensive movement disorder patient clinic for Parkinson's disease (PD) and related neurological movement disorders, all under one roof. Our mission is to find the causes, provide first class patient care and discover a cure. Our unique freestanding organization supports a strong collaboration of translational medicine designed to more directly connect research to patient care – from the "bench to bedside".
The institute was established in 2003 to build on Stanford's leadership in stem cell science and to set the foundations for the creation of a new field of science: regenerative medicine. Under the direction of renowned stem cell researcher Dr. Irving Weissman, the institute is devoted to exploring the how stem cells are created, the mechanisms by which they are regulated and how they devolve into specialized cells.
The ultimate goal is to translate this knowledge into dramatic new medical therapies for some of the world's most serious and intractable afflictions. Finally, as part of Stanford School of Medicine, the institute is dedicated to training the next generation of stem cell researchers.
Stem cell research at University of California, Santa Cruz, focuses on the basic biological systems operating in the processes of self-renewal and differentiation of stem cells.
Stem cells hold great promise for curing or mitigating the effects of many diseases and injuries. But before a single clinical trial can commence, basic research must take place to uncover the pathways, mechanisms, and cellular effects of potential stem-cell-based cures. Basic research is also needed to overcome technological hurdles, such as how to ensure that stem cells work effectively when injected into a living organism. Investment in basic research of the kind done at the IBSC is an essential step toward stem-cell-based cures.
The Center for Biomolecular Science & Engineering administers the UCSC Institute for the Biology of Stem Cells.
BioTime is committed to leading the next revolution in regenerative medicine. Over the past several years, we have made significant progress in building a dominant company in this exciting field. Our strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those new technologies in the treatment of degenerative diseases that afflict large numbers of people worldwide.
Cellerant Therapeutics is a privately-held, clinical-stage biotechnology company with a portfolio of novel innate and adaptive immunotherapies for oncology and blood-related disorders, including cell-based and antibody therapeutics.
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.
Notable Labs is a drug testing service to help oncologists identify actionable treatment options for people with blood cancers.
Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary cell therapy programs are based on its immunotherapy and pluripotent stem cell platform technologies. Asterias is presently focused on advancing three clinical-stage programs which have the potential to address areas of very high unmet medical need in the fields of oncology and neurology.
Internship Host Institution Coordinators
IHI Coordinators provide onsite coordination and supervision for students during their year-long research internship. Coordinators make sure that interns are added to assurance forms and protocols and overall supervise the intern performance and adaptability to the internship lab. Coordinators keep close communication with SJSU mentors to optimize interns performance and satisfaction of both interns and internship lab mentors and PI’s.
Each institution has unique internship opportunities and requirements. It is the IHI Internship Coordinator’s responsibility to assure knowledge and experience in a variety of techniques and to manage the unique opportunities and requirements during the year-long internship.
University of California Santa Cruz
Dr. Tim Fong
Dr. Alex Sulfone
Dr. Diane Heiser
Internship Host Institution Mentors
The IHI research mentors provide in-depth research internship experiences for the students. They have primary responsibility for development and performance of each student’s research plan, and guidance in preparation of the internship research report.
The Parkinson's Institute
Birgitt Schuele, Associate Professor and Program Director
Eugene Butcher, Professor
Michael Clarke, Professor
Christina Curtis, Assistant Professor
Heike Daldrup-Link, Associate Professor
Max Diehn, Assistant Professor
Brian Feldman, Assistant Professor
Ngan Huang, Assistant Professor
Michael Longaker, Professor
Ravi Majeti, Assistant Professor
Peter Manrinkovich, Associate Professor
Theo Palmer, Associate Professor
Giles Plant, Associate Professor
Mathew Porteus, Associate Professor
Maria-Grazia Roncarola, Professor
Julien Sage, Associate Professor
Alejandro Sweet-Cordero, Assistant Professor
Vittorio Sebastiano, Assistant Professor
Susan Tharin, Assistant Professor
Irving Weissman, Professor
Marius Wernig, Associate Professor
Sean Wu, Assistant Professor
Fan Yang, Assistant Professor
University of California, Santa Cruz
Bin Chen, Associate Professor
Camilla Forsberg, Associate Professor
Lindsay Hinck, Professor
Sofia Salama, Research Associate
Daniel Kim, Assistant Professor
David Larocca, Founder and Chief Executive Officer at Mandala Biosciences
Tom Zerembinski, Senior Director At BioTime
Alex Sulfone, Senior Scientist